Clinical Benefit of Cognitive Behaviour Therapy (CBT) for Insomnia in Cancer Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2003 by NHS Greater Clyde and Glasgow.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Cancer Research UK
Information provided by:
NHS Greater Clyde and Glasgow
ClinicalTrials.gov Identifier:
NCT00134108
First received: August 23, 2005
Last updated: October 25, 2005
Last verified: January 2003

August 23, 2005
October 25, 2005
January 2003
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00134108 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Clinical Benefit of Cognitive Behaviour Therapy (CBT) for Insomnia in Cancer Patients
Randomised Controlled Clinical Effectiveness Trial of Cognitive Behaviour Therapy (CBT) Versus Treatment as Usual (TAU) for Insomnia in Cancer Patients

The purpose of this study is to conduct a formal controlled evaluation of the potential benefits of CBT for insomnia in cancer patients.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Insomnia
  • Cancer
Behavioral: Cognitive Behaviour Therapy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
Not Provided
December 2005
Not Provided

Inclusion Criteria:

  • Meets clinical criteria for insomnia.
  • Diagnosis of breast, prostate, colorectal or gynaecological cancer.
  • In follow-up phase with no further anti-cancer therapy planned.

Exclusion Criteria:

  • Anti-cancer chemotherapy or radiotherapy within 4 weeks of trial entry.
  • Evidence of sleep apnoea or other sleep disorder.
  • Evidence of untreated major depressive disorder.
Both
18 Years and older
Not Provided
Contact information is only displayed when the study is recruiting subjects
United Kingdom
 
NCT00134108
C8265/A3036
Not Provided
Not Provided
NHS Greater Clyde and Glasgow
Cancer Research UK
Principal Investigator: Colin Espie, PhD University of Glasgow
NHS Greater Clyde and Glasgow
January 2003

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP